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In order to identify potential novel targets for ultra-
violet-B-induced skin tumorigenesis, we assessed the
effect of ultraviolet-B exposure on cell cycle progres-
sion of transformed keratinocytes with mutant p53.
We show that ultraviolet-B exposure of human epi-
dermoid carcinoma A431 cells results in G1 cell cycle
arrest in both asynchronously growing and synchro-
nized cells. A signi®cant increase in G1 cell popula-
tion was observed following exposure to doses of
ultraviolet-B as low as 10 mJ per cm2. When irradi-
ated with ultraviolet-B, cells synchronized in G1
with mimosine did not exit G1. G1 cell cycle arrest
was associated with a decrease in the hyperphos-
phorylated forms of retinoblastoma protein that was
detectable within 4 h and gradually disappeared by
12 h. We also observed a decrease in cyclins D1, D2,
and D3, and cyclin-dependent kinase 4 proteins, and
a concomitant decrease in cyclin-dependent kinase
4/cyclin D1 associated kinase activity, whereas ultra-
violet-B exposure had no effect on cyclin-dependent
kinase 2 and cyclin-dependent kinase 6 levels during
this time period. Incubation of cells with proteasome
inhibitors MG-115 and MG-132 prevented the
decrease in cyclin D1, D2, and D3, and cyclin-
dependent kinase 4 protein. Taken together, our
results suggest that ultraviolet-B-induced cell cycle
arrest in A431 cells is mediated by cyclin-dependent
kinase 4 downregulation. This identi®es a novel
pathway for G1 cell cycle arrest in transformed kera-
tinocytes following ultraviolet-B irradiation. Key
words: cyclin D/cyclin-dependent kinase 4/proteasome cell
cycle/ultraviolet-B. J Invest Dermatol 118:818±824, 2002
C
oordinated regulation of the cell cycle ensures that
undamaged DNA is replicated faithfully only once
during S phase and that identical copies of chromo-
somes are distributed equally to progeny cells during
M phase (Nurse, 1994). Cell cycle progression
involves highly regulated transitions prior to entry into S phase
and M phase. These transitions are driven by protein kinase
complexes composed of a catalytic subunit and a cyclin regulatory
subunit called cyclin-dependent kinases (CDKs). The periodic
activation and inactivation of CDKs is crucial for the orderly
progression through the cell cycle (Morgan, 1997). The activity of
these enzyme complexes is further modulated by CDK inhibitor
interactions (Sherr and Roberts, 1999).
Progression through G1 requires activation of the cyclin D/
CDK4, cyclin D/CDK6 (Sherr, 1994), and cyclin E/CDK2
complexes (Ohtsubo et al, 1995; Resnitzky and Reed, 1995). D-
type cyclins (D1, D2, and D3) can form complexes with CDK4 and
CDK6, which in turn phosphorylate the retinoblastoma protein
(Rb) on serine and threonine residues. Phosphorylation of Rb leads
to dissociation of Rb from E2Fs, enabling E2Fs to activate a series
of target genes, the expression of which is required for cells to enter
S phase (Hatakeyama and Weinberg, 1995). In addition, CDK4
facilitates activation of CDK2/cyclin E complexes by sequestering
CDK inhibitors of the p21/p27 family (Reynisdottir and Massague,
1997). CDK2/cyclin E is independently required for initiation of
DNA replication. During normal cell cycle progression, the balance
between protein synthesis and protein degradation tightly regulates
cyclin protein levels. Cyclin D1 abundance is regulated by
proteolysis involving two independent mechanisms. During cell
cycle progression cyclin D1 is phosphorylated on threonine 286
following activation of the PI3K/Akt/GSK3-b pathway (Diehl et
al, 1998). This phosphorylation targets cyclin D1 for degradation by
the proteasome. Alternatively, the anaphase promoting complex
(APC) is responsible for the rapid degradation of cyclin D1
following ionizing radiation (Agami and Bernards, 2000). APC-
dependent degradation of cyclin D1 does not require threonine 286
phosphorylation but the presence of a ``cyclin degradation box''
(Agami and Bernards, 2000; Germain et al, 2000).
Surveillance networks working through checkpoints ensure the
timing, order, and accuracy of transmission of genetic material
through cell generations (Hensey and Gautier, 1995; Elledge,
1996). These regulatory networks ultimately control the proper
activation of CDKs. These signaling pathways, also called cell cycle
checkpoints, are evolutionarily conserved from yeast to human.
Surveillance mechanisms work as signal transduction pathways in
which sensors detect DNA damage and activate a signaling cascade
that ultimately leads to cell cycle delay or arrest through the
inhibition of CDKs. Candidate sensor molecules include protein
kinases of the PI3 kinase family; ATM, the gene product mutated
in ataxia telangectasia; ATR, an ATM-related protein; and DNA-
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PK, the DNA-dependent protein kinase. Both p53-dependent and
p53-independent pathways have been identi®ed downstream of
these molecules (Jeggo et al, 1998; Carr, 2000).
Following DNA damage, ATM and ATR can phosphorylate
p53, leading to an increase in both its stability and activity (Banin
et al, 1998; Canman et al, 1998; Khanna et al, 1998; Tibbetts et al,
1999). Activation of p53 through phosphorylation results in the
transcription of a variety of genes that regulate cell cycle
progression, apoptosis, or p53 activity itself. For instance, activation
of p21 is responsible for cell cycle arrest at the onset of S phase.
In a second type of response, ATM and ATR activate Chk1 and
Chk2 protein kinases, which in turn phosphorylate cdc25 leading
to inhibition of its activity by creating a 14-3-3 binding site on
cdc25, and promoting its sequestration in the cytoplasm. This
results in the accumulation of inactivated forms of CDKs
phosphorylated on tyrosine 15 (Brown et al, 1999; Chaturvedi
et al, 1999; Chen et al, 1999; Matsuoka et al, 2000).
It is not yet clear how DNA damage is recognized and what
determines the different types of lesions present in DNA. Most
studies of DNA damage have employed g-irradiation or short-wave
ultraviolet (UVC). The effect of ionizing radiation is believed to be
due to double-strand breaks. UVC radiation does not reach the
earth's surface and therefore is not relevant to the etiology of
human skin cancer. UVB irradiation, which induces speci®c DNA
lesions (cyclobutane pyrimidine dimers and 6±4 photoproducts),
has been determined to be the major cause of nonmelanoma skin
cancer (NMSC) in humans (Gailani et al, 1996).
In normal human keratinocytes, it has been shown that UVB
induces p53 stabilization and activation, which in turn induces the
synthesis of p21, leading to inhibition of CDK2/cyclin E and cell
cycle arrest in G2 mediated by the inhibition of cdc2 through
photophosphorylation on tyrosine 15 (Herzinger et al, 1995).
Here, we have assessed the effects of UVB exposure on cell cycle
progression in transformed keratinocytes (A431 cells) lacking
functional p53. Our results indicate that UVB exposure results in
the accumulation of cells in the G1 phase by downregulating cyclin
D and CDK4 protein and mRNA levels and associated kinase
activity. The downregulation of cyclin D and CDK4 levels may be
the result of UVB-mediated enhancement of proteasome-mediated
degradation of protein kinase subunits.
MATERIALS AND METHODS
UV light source A UV irradiation unit (Daavlin, Bryan, OH)
equipped with an electronic controller to regulate dosage was used. This
UVB source consisted of eight FS72T12-UVB-HO lamps that emit
UVB (290±320 nm, 75%±80% of total energy) and UVA (320±380 nm,
20%±25% of total energy). Further, we used a Kodacel cellulose ®lm
(Kodacel TA401/407) to completely eliminate UVC radiation. The dose
of UVB was quanti®ed with a UVB Spectra 305 Dosimeter (Daavlin).
The radiation was further calibrated with an IL1700 Research
Radiometer/Photometer (International Light, Newburyport, MA). The
radiation source to target distance was maintained at 30 cm. No
measurable increase in ambient temperature was detected during the
irradiation procedure.
Cell culture
Cell line Human epidermoid carcinoma cells (A431) were obtained
from American Type Culture Collection (Manassas, VA) and the cells
were maintained in Dulbecco's modi®ed Eagle's medium supplemented
with 10% fetal bovine serum, 1% penicillin/streptomycin, and 0.5%
fungizone and kept in an atmosphere of 95% air/5% CO2 in a 37°C
humidi®ed incubator according to ATCC guidelines. In all experiments,
80%±85% con¯uent cells were used.
Cell synchronization The cells were synchronized in G1 phase by
incubating them in complete medium containing 0.4 mM mimosine
(Sigma) for 24 h.
UVB treatment The culture medium was removed and the cells were
washed with phosphate-buffered saline (PBS) and exposed to various
doses of UVB through a thin ®lm of PBS. After UVB exposure, cells
were replenished with fresh growth medium and kept for various time
intervals as indicated in the ®gure legends.
Proteasome inhibitor treatment The mimosine-synchronized cells were
treated with various concentrations of proteasome inhibitors MG-115
and MG-132 (Calbiochem) for 3 h prior to irradiation with UVB (10 mJ
per cm2). The proteasome-inhibitor-treated cells were then washed once
with PBS, irradiated, and maintained in the medium containing
proteasome inhibitors for an additional 24 h. Cells were lyzed to assess
the levels of cyclin D and CDK4 and kinase activity.
Cell growth and viability After UVB exposure, the total number of cells
and the number of viable cells were counted using a trypan blue
exclusion assay in addition to assessing a sub-G1 population by ¯ow
cytometric analyses.
Flow cytometric analyses Cells were harvested by trypsinization and low
speed centrifugation. The resulting cell pellet was ®xed in ice-cold 70%
ethanol for at least 30 min at 4°C. Fixed cells were then centrifuged,
washed, resuspended in PBS containing RNAse A (1 mg per ml), and
incubated at 37°C for 30 min. Propidium iodide was added to a ®nal
concentration of 10 mg per ml. Propidium-iodide-stained cells (1±
2 3 106 cells per ml) were analyzed with a ¯uorescence-activated cell
sorter (FACSCaliber, Becton Dickinson) followed by determination of
the percentage of the cells in sub-G1, G1, S, and G2/M by the
CellQuest program.
Preparation of cell lysate Cells were harvested at different time
intervals as mentioned in the ®gure legends by trypsinization. The cells
were washed with ice-cold 1 3 PBS and resuspended in ice-cold lysis
buffer [50 mM HEPES, 150 mM NaCl, 2.5 mM ethyleneglycol-bis(b-
aminoethyl ether)-N,N,N¢,N¢-tetraacetic acid (EGTA), 1 mM ethylene-
diamine tetraacetic acid (EDTA), 1 mM NaF, 1 mM dithiothreitol
(DTT), 0.1% Tween-20, 10% glycerol, pH 7.5, and protease inhibitors]
and sonicated 10 s twice on ice. Clear cell lysate was prepared by
centrifugation at 10,000 3 g for 10 min. It was aliquoted in small
volumes and stored at ±80°C before use.
Immunoblotting Aliquots of total cell lysate were mixed with an
equal volume of sodium dodecyl sulfate (SDS) sample buffer [85 mM
Tris±HCl, pH 6.8, containing 1.4% (wt/vol) SDS, 14% (vol/vol)
glycerol, 5% (vol/vol) mercaptoethanol, and traces of bromophenol
blue], boiled for 5 min, and subjected to SDS polyacrylamide gel
electrophoresis (PAGE). Proteins were electrophoretically transferred to
nitrocellulose membranes. After transfer, membranes were blocked with
5% (wt/vol) nonfat-dry milk in TTBS (0.1% Tween-20, 20 mM Tris
base, 137 mM NaCl, 3.8 mM HCl, pH 7.6) for 2 h at ambient
temperature followed by overnight probing with primary antibody at
4°C [p21waf1/cip1 and p27 (Transduction Laboratory); cyclin D2, cyclin
D3, CDK2, CDK4, and CDK6 (Santa Cruz); cyclin D1 (Transduction
Laboratory and Pharmingen), and Rb (Neomarker)]. After washing the
blot three times in TTBS for 10 min each, the membranes were
incubated for 1 h with horseradish-peroxidase-conjugated secondary
antibody (dilution 1:10,000, Jackson Laboratories, ME). The blot was
washed three times in TTBS for 10 min each and was developed with
ECL according to the manufacturer's instructions (Amersham, Arlington
Heights, IL).
Immunoprecipitation Cells were lyzed in cold lysis buffer consisting
of 50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 2.5 mM
EGTA, 0.1 mM sodium orthovanadate, 1 mM DTT, 0.1% Tween-20,
10% glycerol, 10 mM b-glycerophosphate, 1 mM NaF, and protease
inhibitors. A clear lysate was obtained by sonicating for 15 s on ice
followed by centrifugation at 10,000 3 g for 10 min. The protein
concentration was determined by DC Bio-Rad assay using the
manufacturer's protocol. The cell lysate (500 mg protein) was precleared
with 15 ml of 50% protein A/G sepharose for 1 h at 4°C. Supernatant
was then incubated with the appropriate antibody for 2 h at 4°C
followed by binding to protein A/G sepharose for 1 h at 4°C. Beads
were collected by centrifugation at 3000 rpm for 3 min at 4°C. Immune
complexes were washed three times in lysis buffer, and the pellets were
either suspended in SDS sample buffer for SDS-PAGE electrophoresis or
washed further for kinase assay.
Protein kinase assays As described above, the cyclin±CDK complexes
were immunoprecipitated using appropriate primary antibody and
washed three times with the lysis buffer and once with the kinase buffer
containing 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT,
2.5 mM EGTA, 10 mM b-glycerophosphate, 1 mM NaF, 0.1 mM
Na3VO4. The beads were then incubated in 40 ml kinase buffer
containing either 1 mg of histone H1 (for CDK2 and cyclin E associated
kinase activity) or 1 mg of truncated pRb protein (gift from Dr. C.
Hensey) (for CDK4 and cyclin D associated kinase activity), 20 mM
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adenosine triphosphate (ATP), and 10 mCi of (g-32P) ATP (> 5000 Ci
per mmol, Amersham) for 30 min at 30°C. The samples were separated
on SDS-PAGE and the gel was dried in a Bio-Rad gel drier followed by
exposing to Phosphoimager.
Northern blot analysis Total RNA was isolated using the Quiagen
RNA protocol. The complete coding sequences of human CDK4-
pCMV-CDK4HA (gift from Dr. D. Cobrinik), cyclin D1-PMT-cyclin
D1 (gift from Dr. I.B. Weinstein), and human actin were used to
generate the probes. Autoradiographs were quantitated by laser scanning
densitometer. Measurements of optical density covering the total area of
the bands were integrated and the background was subtracted.
RESULTS
Cell cycle pro®le redistribution of A431 cells following UVB
exposure The effects of UVB were initially examined on cell
viability by analyzing the sub-G1 cell population by ¯ow
cytometric analyses. We observed a dose-dependent increase of
the sub-G1 population (Fig 1A). At low dose of UVB (10 mJ per
cm2) only 5% of irradiated cells showed cytotoxicity and we chose
this dose for most experiments. When exponentially growing A431
cells were exposed to UVB (10 mJ per cm2) we observed a
progressive increase in the G1 population concomitant with a
decrease in the G2 population, whereas the number of cells in S
phase remained approximately constant. By 24 h following UVB
exposure the switch in cell cycle distribution was dramatic as seen
by the increase in G1 cells concomitant with the decrease in G2
cells, whereas the population of cells in S phase remained
unchanged (Fig 1B). The extent of G1 arrest was proportional to
the dose of UVB administered (data not shown). To analyze further
the molecular changes associated with these UVB-induced cell
cycle changes, we synchronized A431 cells in G1 for 24 h with
mimosine, and then released them from the mimosine block prior
to UVB exposure (Orren et al, 1995; Krude, 1999). Mimosine
blocked A431 cells in G1, as seen by the FACS pro®le (Fig 1C,
time 0). UVB treatment occurred after the mimosine block. UVB
irradiation of mimosine-synchronized cells following release from
the G1 block showed no change in the FACS pro®le with the
majority of cells remaining in G1 and some cells in S phase, whereas
control cells released from mimosine rapidly re-entered the cell
cycle with a rapid increase in S phase population that had started at
4 h (data not shown) and was maximum by 6 h (Fig 1C). Because
mimosine induced a high synchrony in G1 and because UVB
irradiation blocked these cells in G1, these experimental conditions
were used subsequently to analyze the molecular basis of the effect
of UVB.
UVB induces accumulation of hypophosphorylated Rb and
disappearance of CDK4 and cyclin D proteins CDK4 and
CDK6 assemble into active enzyme complexes with D-type cyclins
and trigger Rb phosphorylation during mid to late G1, which is a
prerequisite for entry into the S phase. UVB exposure caused a
time-dependent decrease in Rb phosphorylation (Fig 2A). Rb was
present in both hypophosphorylated and hyperphosphorylated
forms at the time of release from mimosine. Following release from
mimosine, Rb became progressively dephosphorylated (Fig 2A).
We observed the stepwise dephosphorylation of Rb with the
presence of phosphorylated intermediates as early as 2 h after
release from mimosine. By 8 h the protein was completely
dephosphorylated. CDK4 protein levels were also greatly reduced
by 6 h and remained low from 8 h on. Cyclin D1 protein levels
decreased with similar kinetics and were no longer detectable by
10 h after release from mimosine (Fig 2A).
Next, we compared the levels of the three D-type cyclins (D1,
D2, and D3), and analyzed the levels of CDK2 and CDK6 protein
(Fig 2B). The three D-type cyclins are encoded by different genes
sharing sequence homology. Cyclin D1, D2, and D3 protein levels
decreased with similar kinetics following UVB irradiation. A very
signi®cant decrease in the level of all three D cyclins was observed
at 8 h and by 24 h almost all the protein had disappeared (Fig 2B,
top panel). In contrast with CDK4, CDK2 protein levels were
unchanged and CDK6 protein levels showed a modest decline up
to 24 h (Fig 2B, middle panel). We also monitored the effect of
UVB irradiation on the level of p21 and p27 CDK inhibitors. UVB
caused the time-dependent downregulation of p21waf1/cip1
protein. The protein was diminished 5 h after UVB irradiation
and became undetectable at 7 h and beyond (Fig 2B, bottom panel).
Levels of p27Kip1 were signi®cantly increased at 8 h and by 24 h
returned to baseline.
UVB reduces the kinase activities of cyclin D and CDK4
complexes Both CDK4 and CDK2 kinase activities are required
Figure 1. Effects of UVB exposure on A431
cells. (A) A431 cells were exposed to different
doses of UVB as indicated and further incubated
for 24 h. Cells were then harvested and the
percentage of the cells in sub-G1 was analyzed by
¯ow cytometry. The average of three independent
experiments is shown. (B) Exponentially growing
A431 cells were exposed to UVB at 10 mJ per
cm2 and harvested 24 h following UVB exposure.
The different populations of cells (G1, S, and G2)
are expressed as percentages of the total cell
population. The corresponding FACS pro®les are
shown as insets (0 and 24) with the value for G1
DNA content (200) and G2 DNA content (400).
(C) Exponentially growing A431 cells were
synchronized with mimosine for 24 h. Following
release from mimosine, cells were either irradiated
with 10 mJ per cm2 UVB (UVB-irradiated) or
mock-irradiated (Control) and harvested at the
times indicated. The different populations of cells
(G1, S, and G2) are expressed as percentages of
the total cell population. The data represent the
average of three independent experiments.
820 KIM ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
for progression of cells through G1 and for entry into S phase. To
determine the effect of UVB on CDK4-dependent kinase activities,
we immunoprecipitated these complexes using antibodies to
CDK4 and cyclin D1 (Fig 3A, B) and assessed kinase activities
of the immune complexes using truncated pRb as substrate. As in
the previous experiments, A431 cells were ®rst synchronized with
mimosine, then released from the mimosine block, and
immediately thereafter irradiated with UVB. In mimosine-
arrested cells, both CDK4 and cyclin D1 associated kinase
activities were low. Release from the mimosine arrest was
followed by the rapid stimulation of CDK4 and cyclin D1
associated kinases as cells progressed through G1. Consistent with
the Rb phosphorylation pattern, UVB exposure of A431 cells
resulted in a time-dependent decrease in cyclin D1/CDK4-
dependent kinase activity at 8 h, which by 24 h was
undetectable. In contrast, in mock-irradiated cells both CDK4
and cyclin D1 associated kinase activity were readily detectable 24 h
after mimosine release (Fig 3A, B, no UVB). In each case, the
decrease in CDK4 and cyclin D1 associated protein kinase activity
correlated with the decrease in CDK4 and cyclin D1 proteins,
respectively. Further, to determine the effect of UVB on CDK2-
dependent kinase activity, we immunoprecipitated these complexes
using CDK2 antibody and assessed kinase activity of the immune
complexes using histone H1 as substrate. Unlike CDK4 kinase
activity, CDK2-dependent kinase was not affected as dramatically
and was still present at 24 h although somewhat reduced (Fig 3C).
This may be a consequence of the prolonged cell cycle arrest due to
downregulation of CDK4/cyclin D1.
UVB reduces RNA levels of cyclin D and CDK4 To
determine whether the decrease in cyclin D and CDK4 protein
levels was transcriptionally regulated, we followed the RNA levels
after UVB exposure. Northern blot analysis of cyclin D1 and
CDK4 is shown in Fig 4. RNA levels of cyclin D1 and CDK4
Figure 2. UVB induces hypophosphorylation of Rb and a time-
dependent decrease in CDK4 and cyclins D1, D2, and D3. (A)
UVB induces hypophosphorylation of Rb. Synchronized A431 cells
were exposed to 10 mJ per cm2 of UVB and cells were harvested at the
indicated time after UVB exposure. The ®rst lane in each panel (0)
corresponds to mock-irradiated, exponentially growing cells. Total Rb
was detected by western blot and two major forms of the protein can be
resolved: hypophosphorylated and phosphorylated (p) Rb. (B) Western
blot analyses of D-type cyclins and other cell cycle regulators, as
indicated following the same procedure as in (A).
Figure 3. UVB reduces the kinase activities of cyclin D1 and
CDK4 complexes. Synchronized A431 cells were exposed to UVB and
harvested at the indicated times after UVB exposure (hours after UVB
exposure). A mock-irradiated control at 24 h following mimosine release
is shown on the last lane of each panel (No UVB). CDK4-associated (A)
and cyclin-D1-associated (B) kinase activities were assessed for kinase
activity using truncated pRb as substrate. CDK2/cyclin E associated
kinase activity was determined (C) using histone H1 as substrate
following immunoprecipitations. For each protein (A, B and C), the top
panel shows the kinetics of associated kinase activity and the bottom
panel shows the protein levels at the same time points.
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decreased by 8 h and by 24 h RNA was virtually undetectable.
When compared to the protein pro®les, it appears that the
disappearance of cyclin D1 and CDK4 proteins preceded that of
RNA, suggesting that the primary effect of UVB is post-
transcriptional downregulation of cyclin D1 and CDK4.
Proteasome inhibitors protect against UVB-induced
decrease in cyclin D and CDK4 levels To determine the
mechanism whereby CDK4 and D-type cyclin proteins were
downregulated following UVB irradiation, we investigated the
possibility of changes in either protein stability or protein synthesis.
As protein degradation by the ubiquitin/proteasome pathway is
known to regulate the abundance of cell cycle proteins, we tested
the effects of two proteasome inhibitors MG-115 and MG-132 on
UVB-induced disappearance of cyclin D1 and CDK4. Pre-
incubation of cells with the proteasome inhibitors MG-115 and
MG-132 at various concentrations followed by exposure to UVB
prevented the disappearance of cyclins D1, D2, and D3 and the
decrease in CDK4 proteins, as shown in Fig 5(A). CDK4 and
cyclin D complex-dependent kinase activity could not be restored
in proteasome-inhibitor-treated cells, however. No CDK4 or
cyclin D1 associated kinase activities could be immunoprecipitated
from UVB-irradiated cells treated with proteasome inhibitors
(Fig 5B). Next, we determined whether cyclin D1 and CDK4
were found in a complex following UVB and proteasome inhibitor
treatment. Although both CDK4 and cyclin D1 proteins were
stabilized by proteasome inhibitors (Fig 5A, B), we could not
detect a complex between the proteins. Immunoprecipitation with
cyclin D1 antibodies did not coprecipitate CDK4 protein (Fig 5C).
This accounts for the lack of kinase activity we observed in both
CDK4 and cyclin D1 immunoprecipitates. MG-115 and MG-132
at the concentrations tested were not cytotoxic as determined by
trypan blue dye exclusion. These results suggest that UVB induces
ubiquitin-mediated proteolysis of cyclin D/CDK4 complexes.
DISCUSSION
The mechanisms whereby the genotoxic stress caused by UVB
radiation alters cell cycle checkpoints are still not clearly de®ned. A
better understanding of cell cycle alterations taking place following
UVB irradiation is essential for explaining the carcinogenic effects
of UVB. Indeed, solar radiation and in particular its UVB
component is a ubiquitous environmental carcinogen and a
known risk factor for NMSC (basal cell and squamous cell
carcinomas) in humans (Gailani et al, 1996). More than 1 million
patients are diagnosed annually with NMSC in the U.S.A. (Black
et al, 1997). In addition to the induction of skin cancers both in
humans and experimental animals, UVB has many other effects in
skin including sunburn, photoaging, and immunosuppression
(Brash et al, 1996). It has been shown that UVB induces signature
mutations in cutaneous DNA (Sarasin, 1999). Mutations of the p53
Figure 4. UVB reduces the RNA levels of cyclin D1 and CDK4.
Total RNA was isolated from A431 cells at different time points
following UVB exposure. The complete coding sequences of human
CDK4-pCMV-CDK4HA (gift from Dr. D. Cobrinik) and cyclin D1-
PMT-cyclin D1 (gift from Dr. I. B. Weinstein) were used to generate
cDNA probes to detect RNAs for cyclin D1 (top panel), CDK4 (middle
panel), and actin (bottom panel) by northern blot analyses. Actin was used
as a loading control.
Figure 5. Proteasome inhibitors protect A431 cells against the
UVB-induced degradation of cyclin D and CDK4. (A) A431 cells
were synchronized at G1 phase in the presence of 0.4 mM mimosine for
24 h and treated with proteasome inhibitors (MG-115 or MG-132, as
indicated) at various concentrations for 3 h. Cells were then exposed to
UVB at 10 mJ per cm2 followed by an additional 24 h incubation in the
presence of proteasome inhibitors at the concentration indicated. Total
lysate was prepared at the end of incubation and the levels of D-type
cyclins and CDK4 were analyzed by western blotting. (B) Stabilization of
CDK4 and cyclin D1 proteins does not restore the kinase activity of
CDK4/cyclin D complexes. A431 cells were treated with proteasome
inhibitors as described in (A). Total lysate was subjected to
immunoprecipitation of CDK4/cyclin D1 complexes followed by kinase
assay using pRb as the substrate (top panel). The ®rst and sixth lanes are
positive controls showing CDK4 and cyclin D1 associated kinase
activities, respectively (No UVB). The same samples from UVB-treated
cells were processed for western blot with CDK4 or cyclin D1
antibodies (bottom panel). (C) A431 cells were treated with proteasome
inhibitors as in (A) and (B). Twenty-®ve micrograms of cell lysates were
processed for western blot with CDK4 antibodies (left panel). Control
cells (0) were irradiated but not treated with proteasome inhibitor. The
same lysates (250 mg) were immunoprecipitated with cyclin D1
antibodies followed by western blot with CDK4 antibodies (right panel).
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gene have been identi®ed in more than 50% of NMSC (Brash et al,
1991; Ziegler et al, 1993). As p53 is a critical sensor of genotoxic
insult that can mediate G1 cell cycle arrest or apoptosis, it has been
dif®cult to determine whether skin tumorigenesis associated with
p53 mutations is a consequence of defective cell cycle arrest, the
abrogation of the apoptosis response, or both. Nothing is known
about the molecular aberrations occurring in NMSC that do not
harbor p53 mutations. As one approach to de®ne these changes we
chose to study UVB-induced cell cycle alterations in a cell line with
mutant, inactive p53 protein. The doses of UVB capable of
evoking these responses in vivo in humans range from 30 to 150 mJ
per cm2. The doses employed in our studies of keratinocytes in
culture are similar to the irradiation dose reaching the basal
keratinocytes of the skin in vivo (de Gruijl, 1999).
Using A431 carcinoma cells, we observed that UVB promoted
an increase in cells in G1 concomitant with a decrease in cells in
G2, whereas cells in S phase remained constant. When A431 cells
were initially synchronized in G1, UVB irradiation prevented them
from entering S phase. G1 arrest was associated with a decrease in
the hyperphosphorylated forms of Rb. We also observed a decrease
in cyclins D1, D2, and D3, and CDK4 proteins associated with a
decrease in CDK4/cyclin D1 associated protein kinase activity.
This probably explains the inability of cells in G1 to progress
through the G1±S transition. In addition, UVB-irradiated cells
progress slowly through S phase. This is in agreement with previous
work reporting that UV irradiation slows down DNA replication
fork progression due to the dif®culty in replicating UV-damaged
DNA templates (McGregor, 1999). This contrasts with what occurs
in normal human skin keratinocytes carrying wild-type p53 and
immortalized human skin keratinocytes (HaCaT cells) carrying
mutant p53 (Herzinger et al, 1995; Petrocelli et al, 1996). Whereas
normal keratinocytes show a p53-dependent delay in G1, HaCaT
cells exhibited G2/M arrest attributable to rapid inhibition of
cyclin-B-associated cdc2 kinase activity with increased tyrosine
phosphorylation of cdc2 (Herzinger et al, 1995; Athar et al, 2000).
The G1 arrest of normal keratinocytes is associated with induction
of wild-type p53, whereas G2/M arrest in HaCaT cells occurs
independently of wild-type p53.
Our results show that UVB irradiation can activate a novel cell
cycle checkpoint that is not dependent upon the activity of wild-
type p53. This checkpoint results in the degradation of both the
catalytic and regulatory subunits of CDK4/cyclin D protein
kinases. This is in contrast with other DNA-damage-induced
checkpoints where inactivation of CDKs is achieved by phos-
phorylation (Costanzo et al, 2000), a more easily reversible arrest
mechanism than protein degradation. The kinetics of CDK4/cyclin
D1 kinase inactivation following UVB do not allow to rule out
that, in addition to cyclin D1 and CDK4 degradation, a second
mechanism participates in the UVB-induced G1 arrest. We believe
that the UVB-induced degradation of CDK4/cyclin D1 complex is
critical, however, for ef®cient cell cycle arrest as it is irreversible.
Interestingly, cyclin D1 is overexpressed in some skin carcinomas
(Bianchi et al, 1993; Robles and Conti, 1995; Inohara et al, 1996).
This overexpression might be due to the failure of some cells to
downregulate cyclin D1 following UVB irradiation. It will be
important to further dissect the molecular basis of this signaling
pathway as it might provide additional information concerning the
events leading to UVB-induced skin carcinogenesis independent of
p53 mutations.
Interestingly, in A431 cells lacking functional p53, we observed a
relatively slow cell cycle response to UVB. The decrease in Rb
phosphorylation was detectable after 2 h whereas reduction in
CDK4 and D-type proteins was apparent by 7 h. This is
comparable to the UVB-induced cell cycle arrest observed in
cells with wild-type p53. Taken together, our results suggest that
UVB-induced damage may not elicit the more rapid cell cycle
response observed in cells exposed to the genotoxic stress of
g-irradiation (Agami and Bernards, 2000). Ionizing radiation causes
DNA double-strand breaks that may stimulate different pathways
than the UVB-induced structural changes of cyclobutane dimers
and 6:4 pyrimidine±pyrimidone photoproducts. In Xenopus,
sensing double-strand breaks results in the rapid inactivation of
CDK2 taking place within 15 min (Costanzo et al, 2000). It was
recently demonstrated that ionizing radiation can induce G1 arrest
independently of p53 in several cell lines (Agami and Bernards,
2000; Mailand et al, 2000).
The cell cycle response induced by UVB involves the degrad-
ation of both the catalytic and the regulatory subunits of the
CDK4/cyclin D complexes. This suggests that it is a response suited
for long-term cell cycle arrest allowing coordinated repair of UVB-
induced DNA lesions. Indeed, re-entry into the cell cycle under
these conditions requires de novo synthesis of the CDK4 and cyclin
D subunits. In addition, the downregulation of CDK4 and cyclin D
might also involve transcriptional alteration as we observed a
decrease in their transcript levels. This decrease occurs only after
Rb dephosphorylation has begun, however, and after the decrease
in cyclin D1 protein, strongly suggesting that the initial down-
regulation is taking place post-transcriptionally and that the primary
effect of UVB irradiation is at the level of protein abundance. We
reasoned that the fast disappearance of D-type cyclins following
UVB might be due to ubiquitin-dependent proteolysis by activated
proteasomes. Our observation that UVB-induced disappearance of
CDK4 and cyclin D1 was abrogated in cells pretreated with two
different proteasome inhibitors strongly suggests that UVB induces
ubiquitin-mediated degradation of these proteins. It is possible that,
in addition to proteasome-dependent degradation, UVB also leads
to the decrease in CDK4 and cyclin D1 synthesis.
Inhibiting the degradation of CDK4 and cyclin D1 was not
suf®cient to restore kinase activity associated with the complexes.
This could be due to the inability of proteasome inhibitors to
prevent the addition of ubiquitin chains, which could interfere with
kinase activity or with the ability of the proteins to exist as a stable
complex. Indeed, following UVB irradiation and treatment with
proteasome inhibitors, we observed that stabilized CDK4 and
cyclin D1 were no longer able to form a complex. Alternatively,
inactivation of CDK4/cyclin D protein kinases could be mediated
by a separate mechanism. It has been shown that UVC can induce
phosphorylation of CDK4 on tyrosine 17 rendering the protein
inactive and promoting cell cycle arrest (Terada et al, 1995). We
were not able to detect inactive CDK4±cyclin D1 complexes
following UVB irradiation, however. The disappearance of CDK4
and cyclin D1 associated kinase activities correlates with the
degradation of the proteins, suggesting that the kinase activity is
regulated by protein abundance rather than by an alternative
inhibitory mechanism.
Recent studies have shown that infrared induces p53-indepen-
dent cell cycle arrest leading to rapid degradation of cyclin D1
(Agami and Bernards, 2000). It will be important to determine
whether UVB-induced downregulation of cyclin D1/CDK4 uses
similar mechanisms. It is also known that the turnover of D-type
cyclins is regulated by ubiquitination and proteasomal degradation,
which is positively regulated by cyclin D1 phosphorylation on
threonine 286 (Diehl et al, 1998). It will be important to determine
whether the targeting of cyclin D1 to the proteasome following
UVB irradiation is also regulated in a similar manner. It has also
been shown that proteasomal degradation is enhanced by binding
of cyclin D1 to CDK4 but is independent of CDK4 catalytic
activity. A similar decrease in D-type cyclins has been observed
following treatment with the antibiotic herbimycin A, which
induces Rb-dependent G1 block characterized by an early decline
in D-cyclins in epithelial tumor cells (Yamada et al, 1996).
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